03:31 AM EST, 12/06/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said late Thursday it has agreed to divest all shares of Teva Takeda Pharma and its Teva Takeda Yakuhin subsidiary to JKI, which was established by the fund managed and operated by J-Will Partners.

Financial terms were not disclosed.

All the employees of the transferred business venture will remain employed, the company said.

Teva said the divestment, expected to be completed by April 1, will allow it to focus on its medicines business in Japan.